Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

Potential antiischemic/antiarrhythmic agent reported

Nov. 8, 1996

Suntory's new sodium/calcium channel blockers

Nov. 8, 1996

Second-generation nitroglycerin patch submitted in Spain

Nov. 8, 1996

Development of Scotia's restenosis Rx back on track

Nov. 8, 1996

Antianginal and antiulcer agents from Sankyo

Nov. 8, 1996

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Teva generic drug licensed by FDA

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...